You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sickle Beta Thalassemia

Showing 1 - 25 of 4,085
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mitapivat in Subjects With Sickle Cell Disease

Enrolling by invitation
  • Sickle Cell Anemia
  • +7 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Pumilio1 Expression, Sickle Cell Anemia, ß-thalassemia

    Not yet recruiting
    • Sickle Cell Disease, Beta Thalassemia Intermedia
    • RNA Binding Protein Pumilio1 (PUM1) Expression by reverse transcriptase quantatative PCR
    • (no location specified)
    May 30, 2023

    Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)

    Recruiting
    • Sickle Cell Anemia
    • Beta Thalassemia
    • TBI
    • +6 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

    Recruiting
    • Sickle Cell Disease
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Sickle Cell Disease, Sickle Cell Trait, Beta-Thalassemia Trial (High performance liquid chromatography, Automated sickling test,

    Not yet recruiting
    • Sickle Cell Disease
    • +4 more
    • High performance liquid chromatography
    • +5 more
    • (no location specified)
    Aug 17, 2022

    Sickle Cell Disease, Hb-SS Disease, Hemoglobin S Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

    Not yet recruiting
    • Sickle Cell Disease
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jun 21, 2023

    Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)

    Not yet recruiting
    • Beta-Thalassemia
    • +6 more
    • CTX001
    • (no location specified)
    Jul 26, 2022

    Human Biospecimens for Basic and Clinical Research Into Globin

    Recruiting
    • Alpha and Beta Thalassemia
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 26, 2023

      Sickle Cell Disease, Thalassemia, Beta, Thalassemia Trial in United States (Fludarabine, Cyclophosphamide, Tacrolimus)

      Recruiting
      • Sickle Cell Disease
      • +2 more
      • Basking Ridge, New Jersey
      • +5 more
      Feb 17, 2023

      After Ex-vivo Gene Therapy With BIVV003 in Severe Sickle Cell

      Recruiting
      • Blood and Lymphatic Diseases
      • Detroit, Michigan
        Investigational Site Number :8400001
      Jul 6, 2022

      A Long-term Follow-up Study in Subjects Who Received CTX001

      Enrolling by invitation
      • Beta-Thalassemia
      • +6 more
      • CTX001
      • New York, New York
      • +12 more
      Nov 18, 2022

      Sickle Cell Disease, Thalassemia Major Trial in Philadelphia (CliniMACS)

      Recruiting
      • Sickle Cell Disease
      • Thalassemia Major
      • CliniMACS
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Dec 22, 2021

      Sickle Cell Anemia Trial run by the NHLBI (PBSC Transplant, Alemtuzumab, Sirolimus)

      Active, not recruiting
      Has Results
      • Sickle Cell Anemia
      • PBSC Transplant
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Oct 13, 2022

      Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA

      Recruiting
      • Sickle Cell Anemia
      • +2 more
      • CD3/CD19 depleted leukocytes
      • +6 more
      • Pittsburgh, Pennsylvania
        Children's Hospital of Pittsburgh of UPMC
      May 4, 2022

      Congenital Hemolytic Anemia, Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Peripheral

      Recruiting
      • Congenital Hemolytic Anemia
      • Sickle Cell Disease
      • Peripheral blood hematopoietic progenitor cell (PBPC) transplant
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Sickle Cell Disease, Sickle Beta Zero Thalassemia, Sickle B+ Thalassemia Trial in Chicago (MED-Go App)

      Recruiting
      • Sickle Cell Disease
      • +3 more
      • MED-Go App
      • Chicago, Illinois
        Ann & Robert H Lurie Children's Hospital of Chicago
      Mar 7, 2022

      Study of the Role of Genetic Modifiers in Hemoglobinopathies

      Recruiting
      • Sickle Cell Disease
      • +3 more
      • GWAS
      • Boston, Massachusetts
      • +24 more
      Apr 4, 2023

      Sickle Cell Disease, Sickle-Cell; Hemoglobin Disease, Thalassemia, Sickle Cell-beta-thalassemia Trial in Jamaica, United Kingdom

      Completed
      • Sickle Cell Disease
      • +3 more
      • Kingston, Jamaica
      • +5 more
      Feb 10, 2022

      Sickle Cell Disease, Beta Thalassemia Trial in New York (Busulfan, Fludarabine, Alemtuzumab)

      Active, not recruiting
      • Sickle Cell Disease
      • Beta Thalassemia
      • New York, New York
        Morgan Stanley Children's Hospital, New York-Presbyterian, Colum
      Aug 12, 2021

      A Single-Site Tissue Repository Providing Annotated Biospecimens

      Recruiting
      • Age-Related Macular Degeneration
      • +46 more
      • Specimen sample
      • Waltham, Massachusetts
        Sanguine Biosciences
      Nov 22, 2022

      Myeloid Chimerism Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (CliniMACS CD34 Reagent)

      Recruiting
      • Myeloid Chimerism
      • CliniMACS CD34 Reagent
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Apr 7, 2022

      Sickle Cell Disease, Beta Thalassemia-Major Trial in New Hyde Park (alemtuzumab (Campath IH), Fludarabine, Melphalan)

      Completed
      Has Results
      • Sickle Cell Disease
      • Beta Thalassemia-Major
      • alemtuzumab (Campath IH)
      • +6 more
      • New Hyde Park, New York
        Cohen Children's Medical Center of New York
      Jul 30, 2021

      Sickle Cell Disease Trial in United States (Defibrotide)

      Recruiting
      • Sickle Cell Disease
      • Los Angeles, California
      • +3 more
      Mar 29, 2022

      Sickle Cell Disease, Sickle B+ Thalassemia, Sickle Beta Zero Thalassemia Trial in Chicago (HU-Go app)

      Completed
      • Sickle Cell Disease
      • +3 more
      • HU-Go app
      • Chicago, Illinois
        Ann & Robert H Lurie Children's Hospital of Chicago
      Jul 27, 2021

      Sickle Cell Disease, Sickle-Beta Zero Thalassemia Trial in Brooklyn (SCD-101)

      Recruiting
      • Sickle Cell Disease
      • Sickle-Beta Zero Thalassemia
      • Brooklyn, New York
        King's County Hospital
      Feb 19, 2021